| Filed On | Filing |
|---|---|
| 26 Mar 2026 |
Form 3: Mancini Anthony, See Remarks
Holds 54,400 shares of Common Stock |
| 26 Mar 2026 |
Form 3: Sandler Alan B., Chief Development Officer
Holds 53,000 shares of Common Stock |
| 07 Aug 2024 |
Form 3: Clyburn Frank, Director
No securities owned |
| 29 Mar 2024 |
Form 3: Wei Lin, Chief Medical Officer
Holds 74,400 shares of Common Stock |
| 14 Nov 2023 |
Form 3: Horning Sandra, Director
No securities owned |
| 29 Mar 2023 |
Form 3: Cislini Jeff, General Counsel
Holds 45,596 shares of Common Stock |
| 13 Jul 2022 |
Form 3: Kim Lorence H., Director
No securities owned |
| 17 Jun 2022 |
Form 3: Patel Sushil, Director
No securities owned |
| 24 Jun 2021 |
Form 3: Borellini Flavia, Director
No securities owned |
| 08 Mar 2021 |
Form 3: Wang Xiaolin, See Remarks
Holds 744 shares of Common Stock |
| 19 Jun 2020 |
Form 3: Schmidt Eric Thomas, Director
No securities owned |
| 12 Feb 2020 |
Form 3: Third Rock Ventures III, L.p., 10% owner and 8 others
Holds 411,006 shares of Common Stock |
| 12 Feb 2020 | Form 3: Flynn James E, 10% owner and 5 others |
| 12 Feb 2020 | Form 3: Third Rock Ventures IV, L.p., 10% owner and 2 others |
| 12 Feb 2020 |
Form 3: Miller Vincent A., Director
Holds 30,825 shares of Common Stock |
| 12 Feb 2020 |
Form 3: Schroeder Thilo, Director
No securities owned |
| 12 Feb 2020 |
Form 3: Kelsey Stephen Michael, See Remarks
Holds 268,009 shares of Common Stock |
| 12 Feb 2020 |
Form 3: Exter Neil, Director
Holds 0 shares of Common Stock |
| 12 Feb 2020 |
Form 3: Goldsmith Mark A, Director
Holds 493,208 shares of Common Stock |
| 12 Feb 2020 |
Form 3: Horn Margaret A, See Remarks
Holds 123,302 shares of Common Stock |
Loading...